Highlights Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Market Closed - Nasdaq Other stock markets 01:30:00 21/05/2024 am IST			5-day change	1st Jan Change
5.67 ^USD	+6.18%		+4.61%	+9.88%

14/05	Transcript : Sight Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:15 AM
03/05	Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed	03/05	MT
Earnings Flash (SGHT) SIGHT SCIENCES Reports Q1 Revenue $19.3M, vs. Street Est of $18.4M	03/05	MT
Sight Sciences, Inc. Provides Revenue Guidance for the Second Half of 2024 and Re-Affirms Earnings Guidance for the Full Year 2024	03/05	CI
Sight Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05	CI
Sector Update: Health Care Stocks Edge Higher Late Afternoon	30/04	MT
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	29/04	MT
Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump	29/04	MT
Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump	29/04	MT
Sight Sciences, Inc. Announces the Publication of Large-Scale, Real-World Migs Study	11/04	CI
Sector Update: Health Care Stocks Flat Pre-Bell Wednesday	03/04	MT
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Extend Gains to Premarket	03/04	MT
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Jump After Hours	03/04	MT
Sight Sciences, Inc. Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT At the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	03/04	CI
Earnings Flash (SGHT) SIGHT SCIENCES Reports Q4 Revenue $18.8M, vs. Street Est of $19.4M	08/03	MT
Sight Sciences, Inc. Provides Earnings Guidance for the Year 2024	08/03	CI
Sight Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03	CI
Sight Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03	CI
Sight Sciences, Inc. Announces European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting	15/02	CI
Sight Sciences Expects Lower Q4, Higher Full-Year 2023 Revenue	09/01	MT
Sight Sciences, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	09/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Highlights

Filters